Asprosin Exerts Pro-Inflammatory Effects in THP-1 Macrophages Mediated via the Toll-like Receptor 4 (TLR4) Pathway
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Asprosin Exerts Pro-Inflammatory Effects in THP-1 Macrophages Mediated via the Toll-like Receptor 4 (TLR4) Pathway
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 1, Pages 227
Publisher
MDPI AG
Online
2022-12-23
DOI
10.3390/ijms24010227
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NUCB2/Nesfatin-1 Reduces Obesogenic Diet Induced Inflammation in Mice Subcutaneous White Adipose Tissue
- (2022) Seley Gharanei et al. Nutrients
- Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38/Elk-1 pathway
- (2022) Jin Zou et al. Journal of Translational Medicine
- High Serum Asprosin Levels Are Associated with Presence of Metabolic Syndrome
- (2021) Tao Hong et al. International Journal of Endocrinology
- Molecular Mechanisms of Apoptosis Induction and Its Regulation by Fatty Acids in Pancreatic β-Cells
- (2021) Jan Šrámek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Asprosin serum levels and glucose homeostasis in children with obesity
- (2021) Domenico Corica et al. CYTOKINE
- Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence
- (2021) Kiran Shabir et al. CYTOKINE & GROWTH FACTOR REVIEWS
- A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer
- (2021) Rachel Kerslake et al. Oncology Letters
- Adipose tissue immune cells in obesity, type 2 diabetes mellitus and cardiovascular diseases
- (2021) Anna Cinkajzlová et al. JOURNAL OF ENDOCRINOLOGY
- Obesity and Diabetes
- (2021) Mohini Aras et al. NURSING CLINICS OF NORTH AMERICA
- Increased Serum Circulating Asprosin Levels in Children with Obesity
- (2020) Eda Sünnetçi Silistre et al. PEDIATRICS INTERNATIONAL
- TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice
- (2020) Yuko Ono et al. Scientific Reports
- Obesity, Hypertension, and Cardiac Dysfunction
- (2020) Alan J. Mouton et al. CIRCULATION RESEARCH
- The Asprosin–OLFR734 module regulates appetitive behaviors
- (2020) Yang Liu et al. Cell Discovery
- The role of Asprosin in patients with dilated cardiomyopathy
- (2020) Ming-Shien Wen et al. BMC Cardiovascular Disorders
- Assessment of acute aerobic exercise in the morning versus evening on asprosin, spexin, lipocalin-2, and insulin level in overweight/obese versus normal weight adult men
- (2020) Halil İbrahim Ceylan et al. CHRONOBIOLOGY INTERNATIONAL
- TLR4 signaling and macrophage inflammatory responses are dampened by GIV/Girdin
- (2020) Lee Swanson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity
- (2020) Tatsuo Kawai et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Expression and purification of asprosin in Pichia pastoris and investigation of its increase glucose uptake activity in skeletal muscle through activation of AMPK
- (2020) Yunhua Zhang et al. ENZYME AND MICROBIAL TECHNOLOGY
- Saliva and Blood Asprosin Hormone Concentration Associated with Obesity
- (2019) Kader Ugur et al. International Journal of Endocrinology
- Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications
- (2019) Michele Longo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscle
- (2019) Tae Woo Jung et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation
- (2019) Taeseung Lee et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin
- (2019) Erwei Li et al. Cell Metabolism
- Adipokine dysregulation and adipose tissue inflammation in human obesity
- (2018) Xabier Unamuno et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Dynamics of adipose tissue turnover in human metabolic health and disease
- (2018) Ursula White et al. DIABETOLOGIA
- Serum asprosin levels and bariatric surgery outcomes in obese adults
- (2018) Chao-Yung Wang et al. INTERNATIONAL JOURNAL OF OBESITY
- Asprosin is a centrally acting orexigenic hormone
- (2017) Clemens Duerrschmid et al. NATURE MEDICINE
- Asprosin, a Fasting-Induced Glucogenic Protein Hormone
- (2016) Chase Romere et al. CELL
- In vitro effect of caffeic acid phenethyl ester on matrix metalloproteinases (MMP-1 and MMP-9) and their inhibitor (TIMP-1) in lipopolysaccharide-activated human monocytes
- (2015) Polyana das Graças Figueiredo Vilela et al. ARCHIVES OF ORAL BIOLOGY
- Eosinophils Reduce Chronic Inflammation in Adipose Tissue by Secreting Th2 Cytokines and Promoting M2 Macrophages Polarization
- (2015) Yi Zhang et al. International Journal of Endocrinology
- Macrophages and the Regulation of Adipose Tissue Remodeling
- (2014) Gabriel Martinez-Santibañez et al. Annual Review of Nutrition
- Signaling pathway of autophagy associated with innate immunity
- (2014) Yi Xu et al. Autophagy
- From excess adiposity to insulin resistance: The role of free fatty acids
- (2012) Cristiano Capurso et al. VASCULAR PHARMACOLOGY
- Toll-Like Receptor 4 Inhibitor TAK-242 Attenuates Acute Kidney Injury in Endotoxemic Sheep
- (2011) Johan Fenhammar et al. ANESTHESIOLOGY
- A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*
- (2010) Todd W. Rice et al. CRITICAL CARE MEDICINE
- Effect of Toll-like receptor 4 inhibitor on LPS-induced lung injury
- (2010) Hiroyuki Seki et al. INFLAMMATION RESEARCH
- TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
- (2010) N. Matsunaga et al. MOLECULAR PHARMACOLOGY
- Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model
- (2009) K Takashima et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages
- (2009) Anne Mullen et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Normalization of obesity-associated insulin resistance through immunotherapy
- (2009) Shawn Winer et al. NATURE MEDICINE
- Elevated Toll-Like Receptor 4 Expression and Signaling in Muscle From Insulin-Resistant Subjects
- (2008) S. M. Reyna et al. DIABETES
- TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain
- (2008) Tomohiro Kawamoto et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started